New treatment approach for heart failure using small molecules
Small Molecule Therapeutic for Heart Failure
This study is looking at a new medication that could help people with heart failure by making their hearts work better when responding to important hormones, and it uses special tests and mouse models to see how well it works.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11001484 on NIH RePORTER |
What this research studies
This research investigates a novel small molecule therapeutic aimed at improving heart function in patients with heart failure. It focuses on the mechanisms of beta-adrenergic receptor (βAR) desensitization and resensitization, which are crucial for cardiac function. By targeting specific proteins that regulate these processes, the research aims to enhance the heart's ability to respond to hormones like epinephrine and norepinephrine, potentially leading to better heart performance. The study will utilize advanced biochemical assays and mouse models to evaluate the effectiveness of the treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with heart failure.
Not a fit: Patients with heart failure who are under 21 years old or those with other severe comorbidities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved heart function and quality of life for patients suffering from heart failure.
How similar studies have performed: Previous research has shown promising results in targeting βAR resensitization, indicating potential for success in this novel approach.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Prasad, Sathyamangla V — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Prasad, Sathyamangla V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.